Newsroom
A SNP That Affords Protection From Breast Cancer Identified
The study, published in the journal Nature Communications, identified the single nucleotide polymorphism near the coding region of the estrogen receptor ESR1 among Latina women.
Data Collection, Telehealth, and Importance of Primary Care Physicians Get Attention at ACO Coalition Meeting
Attendees at the ACO and Emerging Healthcare Delivery Coalition meeting held October 16-17, 2014, in Miami, Fla., gained insights to help physicians and accountable care organizations achieve the “Triple Aim” of better population health, greater patient satisfaction, and lower costs. This initiative of The American Journal of Managed Care has now attracted more than 120 members.
ONC Interoperability Roadmap Draft Unveils Guiding Principles
The Office of the National Coordinator for Health Information Technology unveiled a draft for its 10-year plan for healthcare interoperability at a joint meeting on October 15.
New Initiative Seeks to Harness Data to Improve Community Health
A new initiative from the Robert Wood Johnson Foundation will explore how health information and data can be used to improve health in the community.
FDA Allows Testing of Ebola Experimental Drug by Chimerix
Brincidofovir is being developed by the company against several different viruses, including smallpox and Ebola.
CMS Issues Draft Coverage Decision For Prostate Cancer Test by GenomeDX
The Decipher test is intended for use in men who have undergone radical prostatectomy and are at a high risk of disease recurrence.
Myriad’s Prostate Cancer Test Receives Draft Medicare Coverage
Myriad Genetics, Inc., announced today that the Medicare Administrative Contractor (MAC) that has jurisdiction over most molecular diagnostic tests has issued its draft notice on how Medicare will provide reimbursement for Prolaris, a test that Myriad has developed to guide treatment decisions in prostate cancer.
Janssen's Imbruvica Approved by the European Commission
Imbruvica (ibrutinib) is a first-in-class BTK inhibitor with potential for treating blood cancer, indicated for use in MCL and CLL patients.
Roche Joins the Immuno-oncology Front With a PD-L1 inhibitor
While the current approved immuno-oncolgy drugs have been approved for melanoma, Roche has also been evaluating their new molecule in triple-negative breast cancer. The results will be presented at the San Antonio Breast Cancer Symposium.
More Providers, Insurers Showing Appetite for Narrow Networks
Providers and insurers across the country are partnering to launch narrow-network plans even as controversy continues over whether these plans offer adequate provider access for consumers.
Malpractice “Immunity” Does Not Prevent Wasteful Spending
Legal reforms that enact stronger protections against malpractice claims do not necessarily reduce defensive care, according to a new study by the RAND Corporation published in the New England Journal of Medicine.
Massachusetts Caught in Scheme to Over-Charge Medicaid by $106 Million
Massachusetts health officials over-billed Medicaid for almost $106 million by filing claims from as far back as 1988 as current expenses, according to an HHS inspector general's report.
Reducing Hospital Readmissions May Prove Tougher than CMS Expects, AJMC Study Finds
The Centers for Medicare and Medicaid Services wants hospitals to find ways to keep patients from returning to the hospital, and the agency has created rewards and punishments in pursuit of this goal. A study in The American Journal of Managed Care is just one of a pair of recent clinical trials that finds readmissions may be beyond some hospitals’ control, and policymakers might need to rethink their approach.
AMA Calls for More Meaningful Use Flexibility in Letter to CMS, ONC
The strict rules of the Meaningful Use (MU) program are preventing physicians from participating, according to the American Medical Association, which is calling for more flexibility and some relief from penalties.
Policy Changes May be Slow on State Exchanges as IT Systems Evolve
A blog published by The Commonwealth Fund points to digital technology glitches being responsible for slower policy adoption by several state exchanges. But states are fixing their technology glitches and also setting examples for other states to follow, say the authors.
Success of Medicare's Prescription-Subsidy Program Among Low-Income Women
A study presented at ASCO's Quality Care Symposium in Boston found increased medication adherence to prevent breast cancer recurrence in those availing of the subsidies.
Exciting Clinical Results With Novartis' Leukemia Immune Therapy
The regimen, based on reprogramming the patient's immune T cells to attack the cancer cells, led to the disappearance of cancer in 90 percent of patients, according to a study published in the New England Journal of Medicine.
For the Basics, Retails Clinics Just as Good or Better Than Urgent Care or Emergency Rooms, Study Finds
With a shortage of primary care physicians and the costs that come with a trip to the emergency room, can retail clinics fill the gap? A study published today in The American Journal of Managed Care finds they can, offering care that is just as good or better for common ailments like ear infections or strep throat.
CMS Offers Upfront Investment to ACOs Through New Initiative
Accountable Care Organizations participating in the Medicare Shared Savings Program will have access to a new initiative that will support care coordination across the country, according to CMS. Up to $114 million in upfront investments will be made available.
ICD-10 Would Help US Better Track Ebola
If Congress had not pushed back the deadline for implementing ICD-10 last spring, the United States now would have a specific code for tracking Ebola, according to an infographic from the Coalition for ICD-10.
Medicare Advantage Star Ratings Increasing Overall Plan Quality
Quality in Medicare Advantage plans is increasing, and CMS credits the improvement to its star rating system. A growing number of Medicare enrollees are in plans receiving at least 4 out of 5 stars, according to a new fact sheet.
Exact Sciences' Cologuard Receives CMS National Coverage
The non-invasive nature of the test makes it a very attractive alternative to the uncomfortable colonoscopy used to detect colorectal cancer. In a New England Journal of Medicine study of 10,000 patients, the test identified 92% of colorectal cancers in average-risk patients and 42% of polyps.
After Roche, Celgene Faces Value Push-Back From NICE
After Roche saw 2 product rejects a few weeks back from NICE, based on a value argument, Celgene is in a similar boat with it's multiple myeloma drug pomalidomide.
A Look at Coverage Eligibility in Medicaid Nonexpansion States
In states that chose not to expand Medicaid eligibility under the Affordable Care Act, residents with a median income of less than $800 a month are now ineligible for coverage assistance while those with more than $2000 a month are eligible for subsidies, according to a report from the Urban Institute.